ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics.
ProFound Therapeutics has raised $75.0M in total funding. The most recent round was Series A. The last funding was announced in May 2022.
ProFound Therapeutics's investors include Flagship Pioneering.
ProFound Therapeutics is headquartered in Cambridge, United States.
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics.
ProFound Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ProFound Therapeutics — Funding & Investors." VCBacked, May 26, 2022, https://www.vcbacked.co/company/profound-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). ProFound Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/profound-therapeutics
{{cite web |title=ProFound Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/profound-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated